Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2009
03/31/2009US7510831 Expression vector comprising nucleotide sequences coding phytase for use in transformation and expression in aspergillus; enhancing nutrient quality of animal feeds
03/31/2009US7510829 Primers for use in the amplification of preferential nucleotide sequences
03/31/2009US7510828 Therapy, prevention of viral infections; obtaining viron sample; incubation, monitoring, calibration: using antithrombin agent
03/31/2009US7510827 Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup
03/31/2009US7510826 Process for the depletion or removal of endotoxins
03/31/2009US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor
03/31/2009US7510824 Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
03/31/2009US7510735 Measuring the bacterial viability, by acid treatment, bile acid treatment, the bacteria strains are acid resistant
03/31/2009US7510718 Expression vector comprising nucleotide sequences coding multimeric nuclear anchoring-protein for use as tool in transfer, expression and propagation of heterologous gene sequences
03/31/2009US7510643 Accurate direct temperature measurement of sample
03/31/2009US7510637 Microelectronic arrays for cell-based functional genomics/high throughput phenotyping by electrokinetic assembly
03/31/2009US7509880 Fluid flow meter body with high immunity to inlet/outlet flow disturbances
03/31/2009CA2424775C Rapid triglyceride assay for use in pulp pitch control
03/31/2009CA2360543C Binary probe and clamp composition and methods for target hybridization detection
03/31/2009CA2289961C A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
03/31/2009CA2216126C Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
03/31/2009CA2066204C Cystic fibrosis gene
03/26/2009WO2009039507A2 Identification and isolation of fetal cells and nucleic acid
03/26/2009WO2009039484A1 Treatment and prevention of ischemic brain injury
03/26/2009WO2009039479A1 Genotypic tumor progression classifier and predictor
03/26/2009WO2009039476A1 Treatment and prevention of ischemic brain injury
03/26/2009WO2009039457A1 Identification of novel pathways for drug development for lung disease
03/26/2009WO2009039390A2 The development of glycobiology-based therapeutics for the treatment of brain tumors
03/26/2009WO2009039341A2 Neoepitope detection of disease using protein arrays
03/26/2009WO2009039286A2 Frameless multiplexed microarrays
03/26/2009WO2009039284A1 Systems and methods for high-throughput detection and sorting
03/26/2009WO2009039246A2 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
03/26/2009WO2009039244A2 Genemap of the human genes associated with crohn's disease
03/26/2009WO2009039190A1 Cancer risk biomarker
03/26/2009WO2009039170A2 Integrated protein chip assay
03/26/2009WO2009039152A1 Detection of h. pylori utilizing unlabeled urea
03/26/2009WO2009039136A2 Self-actuating signal producing detection devices and methods
03/26/2009WO2009039023A2 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
03/26/2009WO2009038754A2 Gene expression signatures in enriched tumor cell samples
03/26/2009WO2009038748A2 Seed testing method and apparatus
03/26/2009WO2009038742A2 Method for estimating risk of acute kidney injury
03/26/2009WO2009038689A2 Compositions and methods for diagnosis and treatment of type 2 diabetes
03/26/2009WO2009038666A2 Compositions and methods for the identification of inhibitors of retroviral infection
03/26/2009WO2009038607A1 Method for selectiveley staining microorganisms
03/26/2009WO2009038594A2 Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease
03/26/2009WO2009038548A1 Oligonucleotide probes and uses thereof
03/26/2009WO2009038536A1 A device, system and method for washing and isolating magnetic particles in a continous fluid flow
03/26/2009WO2009038079A1 Cell measuring vessel, extracellular potential measuring method, and chemical testing method
03/26/2009WO2009037840A1 Method for measuring substrate concentration and device for the same
03/26/2009WO2009037839A1 Method and kit for detection of substance in cell
03/26/2009WO2009037804A1 Microparticle measuring device and microparticle measuring method
03/26/2009WO2009037659A2 Magnetic detection of small entities
03/26/2009WO2009037635A2 Method for the analysis of breast cancer disorders
03/26/2009WO2009037633A2 Method for the analysis of ovarian cancer disorders
03/26/2009WO2009037575A2 Multiplex pcr assay for identification of usa300 and usa400 community-associated methicillin resistant staphylococcal aureus strains
03/26/2009WO2009037527A2 Methods, systems, and compositions for cancer diagnosis
03/26/2009WO2009037511A1 Assay for dna supercoiling/relaxation
03/26/2009WO2009037492A2 Markers
03/26/2009WO2009037473A2 Nucleobase characterisation
03/26/2009WO2009037441A1 Improved methylation detection
03/26/2009WO2009037438A1 Improved detection of mage-a expression
03/26/2009WO2009037402A2 Hpiv-2 variants and medical applications thereof
03/26/2009WO2009037385A1 Diagnostics of b-cell lymphoma
03/26/2009WO2009037337A1 Robust and tissue independent gender-specific transcript markers for molecular gender determination
03/26/2009WO2009037295A1 Method for testing psoriasis susceptibility
03/26/2009WO2009037266A2 Method for detecting or quantifying a truncating mutation
03/26/2009WO2009037090A1 Molecular markers for tumor cell content in tissue samples
03/26/2009WO2009036976A1 Use of the human photomedin-2 / olfactomedin-like 2b gene (olfml2b), its gene variants and its protein for diagnostic and therapeutic approaches to heart diseases
03/26/2009WO2009036956A1 Detection of staphylococcus aureus in bovine mastitic milk
03/26/2009WO2009036922A2 Novel markers for bladder cancer detection
03/26/2009WO2009036574A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
03/26/2009WO2009036573A1 Apparatus and method for monitoring cell behaviour
03/26/2009WO2009036525A2 Tools and methods for genetic tests using next generation sequencing
03/26/2009WO2009036513A1 Diagnostic and therapeutic protocols
03/26/2009WO2009021150A3 Platelet derived growth factor receptor supports cytomegalovirus infectivity
03/26/2009WO2009017878A9 High specificity and high sensitivity detection based on steric hindrance & enzyme-related signal amplification
03/26/2009WO2009016237A3 Molecular typing of neisseria strains by determining the presence of genes involved in lipooligosaccharide (los) biosynthesis
03/26/2009WO2009012263A3 Tissue-specific micrornas and compositions and uses thereof
03/26/2009WO2009008930A3 Process for making a porous substrate of glass powder formed through flame spray pyrolysis
03/26/2009WO2009007724A3 Diagnosis and treatment of abnormal blood conditions
03/26/2009WO2009004189A3 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
03/26/2009WO2009001095A3 Novel schizophrenia associated genes
03/26/2009WO2009000920A9 Device and method for detecting a substance by means of particle plasmon resonance (ppr) or particle-mediated fluorescence based on cell surface polarizations
03/26/2009WO2008156987A9 Riboswitches and methods and compositions for use of and with riboswitches
03/26/2009WO2008156827A3 Molecular grading methods for ductal carcinoma in situ
03/26/2009WO2008148072A3 Disease-associated genetic variations and methods for obtaining and using same
03/26/2009WO2008147930A3 Methods and kits for linking polymorphic sequences to expanded repeat mutations
03/26/2009WO2008143717A3 Methods of determining lethality of pathogens and malignancies involving replikin peak genes
03/26/2009WO2008139421A3 Electrical transduction method and device for the detection of biorecognition events in biomolecular interaction processes for genome/proteome analysis
03/26/2009WO2008132155A3 Inhibitors of the binding between hdm2 and the proteasome
03/26/2009WO2008112283A3 Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
03/26/2009WO2008110824A3 Diagnostic test for age-related macular degeneration (amd)
03/26/2009WO2008109059A3 Conserved-element vaccines and methods for designing conserved-element vaccines
03/26/2009WO2008021483A3 Prognostic and diagnostic method for disease therapy
03/26/2009WO2007028031A9 Methods and probe combinations for detecting melanoma
03/26/2009WO2007025085A3 Genemap of the human genes associated with crohn's disease
03/26/2009WO2006033942A3 Pik4ca as modifier of the rac pathway and methods of use
03/26/2009WO2005067580A3 Naphthofluorescein-based metal sensors, and methods of making and using the same
03/26/2009WO2005060725A3 Nucleic acid amplification methods
03/26/2009WO2005044977A3 Compositions, splice variants and methods relating to lung specific genes and proteins
03/26/2009WO2005043111A3 Serum biomarkers for sars
03/26/2009WO2005030924A3 Genetic markers for skatole metabolism
03/26/2009WO2005012551A3 Interaction of nmda receptor with protein tyrosine phosphatase
03/26/2009WO2005002521A3 Methods for the identification of inhibitors of acetolactate synthase and potassium transport protein as antibiotics
03/26/2009WO2004104161A3 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
1 ... 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 ... 3003